Nippon Chemical Industrial (4092) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
14 Apr, 2026Executive summary
Net sales rose 16.2% year-over-year to ¥10,379 million in the first quarter of FY March 2025.
Operating profit surged 382.5% year-over-year to ¥1,688 million, with operating margin improving to 16.3% from 3.9%.
Ordinary profit increased 286.5% year-over-year to ¥1,741 million.
Profit attributable to owners of parent increased 334.8% year-over-year to ¥1,252 million.
EBITDA doubled to ¥2,623 million, up 102.5% year-over-year.
Financial highlights
Earnings per share jumped to ¥141.94 from ¥32.68 year-over-year.
Shareholders' equity increased by ¥944 million to ¥40,562 million as of June 2024.
Equity ratio stood at 60.2% at quarter-end, up from 58.9% at the previous fiscal year-end.
Gross profit increased to ¥3,047 million from ¥1,661 million year-over-year.
Total assets grew to ¥77,141 million as of June 30, 2024.
Outlook and guidance
FY March 2025 net sales forecast at ¥40,000 million, up 3.8% from FY March 2024.
Operating profit projected to rise 28.1% to ¥2,900 million for the full year.
Profit attributable to owners of parent expected to reach ¥2,000 million, up 25.7% year-over-year.
Annual dividend forecast maintained at ¥70 per share.
No changes to previously announced projections as of August 2024.
Latest events from Nippon Chemical Industrial
- Operating profit surged 199% and dividend forecast was raised amid ongoing uncertainties.4092
Q2 202514 Apr 2026 - FY2025 profits surged, but FY2026 faces a sharp profit drop despite higher dividends.4092
Q4 202514 Apr 2026 - Operating profit more than doubled year-over-year, driven by strong sales and EPS growth.4092
Q3 202514 Apr 2026 - Full-year profit and dividend forecasts were raised after strong Q1 sales and cost improvements.4092
Q1 202614 Apr 2026 - Sales grew 1.5% but profits fell sharply; full-year outlook and dividend remain steady.4092
Q2 202614 Apr 2026 - Profits fell but comprehensive income and dividends are set to rise amid modest sales growth.4092
Q3 202614 Apr 2026